ELAB vs PCAR · rev $2.0M vs P/E 25, rev $33.66B
Elevai Labs, Inc. Common Stock (ELAB) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
ELAB currently screens at market cap $6.5M. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the ELAB and PCAR stock pages for the full models.
Not investment advice.